CoChat
Sign Up
Cited by 61

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Nicotine Effects and the Endogenous Opioid System

Kishioka, Shiroh, Kiguchi, Norikazu, Kobayashi, Yuka, Saika, Fumihiro·2014·Journal of Pharmacological Sciences
DOI 10.1254/jphs.14r03cp
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1254/jphs.14r03cp

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 47

  1. 2 Jensen AA, Frølund B, Liljefors T, Krogsgaard-Larsen P. Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations. J Med Chem. 2005;48:4705–4745. · DOI
  2. 3 Tripathi HL, Martin BR, Aceto MD. Nicotine-induced antinociception in rats and mice: correlation with nicotine brain levels. J Pharmacol Exp Ther. 1982;221:91–96. · DOI
  3. 4 Zarrindast MR, Pazouki M, Nassiri-Rad S. Involvement of cholinergic and opioid receptor mechanisms in nicotine-induced antinociception. Pharmacol Toxicol. 1997;81:209–213. · DOI
  4. 5 Pajusco B, Chiamulera C, Quaglio G, Moro L, Casari R, Amen G, et al. Tobacco addiction and smoking status in heroin addicts under methadone vs. buprenorphine therapy. Int J Environ Res Public Health. 2012;9:932–942
  5. 6 Liu S1, Zhou W, Zhang J, Wang Q, Xu J, Gui D. Differences in cigarette smoking behaviors among heroin inhalers versus heroin injectors. Nicotine Tob Res. 2011;13:1023–1028. · DOI
  6. 8 Haass M, Kübler W. Nicotine and sympathetic neurotransmission. Cardiovasc Drugs Ther. 1997;10:657–665. · DOI
  7. 9 Gudehithlu KP, Duchemin AM, Tejwani GA, Neff NH, Hadjiconstantinou M. Nicotine-induced changes of brain β-endorphin. Neuropeptides. 2012;46:125–131. · DOI
  8. 10 Boyadjieva NI, Sarkar DK. The secretory response of hypothalamic beta-endorphin neurons to acute and chronic nicotine treatments and following nicotine withdrawal. Life Sci. 1997;61:PL59–PL66. · DOI · Paper page
  9. 11 Houdi AA, Pierzchala K, Marson L, Palkovits M, Van Loon GR. Nicotine-induced alteration in Tyr-Gly-Gly and Met-enkephalin in discrete brain nuclei reflects altered enkephalin neuron activity. Peptides. 1991;12:161–166. · DOI
  10. 12 Isola R, Zhang H, Tejwani GA, Neff NH, Hadjiconstantinou M. Acute nicotine changes dynorphin and prodynorphin mRNA in the striatum. Psychopharmacology. 2009;201:507–516. · DOI
  11. 13 Kiguchi N, Maeda T, Tsuruga M, Yamamoto A, Yamamoto C, Ozaki M, et al. Involvement of spinal Met-enkephalin in nicotine-induced antinociception in mice. Brain Res. 2008;1189:70–77. · DOI
  12. 14 Campbell VC, Taylor RE, Tizabi Y. Antinociceptive effects of alcohol and nicotine: involvement of the opioid system. Brain Res. 2006;1097:71–77. · DOI
  13. 15 Berrendero F, Mendizábal V, Robledo P, Galeote L, Bilkei-Gorzo A, Zimmer A, et al. Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene. J Neurosci. 2005;25:1103–1112. · DOI
  14. 16 Galeote L, Kieffer BL, Maldonado R, Berrendero F. Mu-opioid receptors are involved in the tolerance to nicotine antinociception. J Neurochem. 2006;97:416–423. · DOI
  15. 17 Biała G, Budzyńska B, Kruk M. Naloxone precipitates nicotine abstinence syndrome and attenuates nicotine-induced antinociception in mice. Pharmacol Rep. 2005;57:755–760.
  16. 18 Yamamoto A, Kiguchi N, Kobayashi Y, Maeda T, Ueno K, Yamamoto C, et al. Pharmacological relationship between nicotinic and opioid systems in analgesia and corticosterone elevation. Life Sci. 2011;89:956–961. · DOI
  17. 19 Bannon AW, Decker MW, Holladay MW, Curzon P, Donnelly-Roberts D, Puttfarcken PS, et al. Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. Science. 1998;279:77–81. · DOI
  18. 20 Berrendero F, Kieffer BL, Maldonado R. Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in μ-opioid receptor knock-out mice. J Neurosci. 2002;22:10935–10940. · DOI
  19. 21 Di Cesare Mannelli L, Zanardelli M, Ghelardini C. Nicotine is a pain reliever in trauma- and chemotherapy-induced neuropathy models. Eur J Pharmacol. 2013;711:87–94. · DOI
  20. 22 Rashid MH, Ueda H. Neuropathy-specific analgesic action of intrathecal nicotinic agonists and its spinal GABA-mediated mechanism. Brain Res. 2002;953:53–62. · DOI
  21. 23 Maeda T, Kishioka S. Chapter 13 PPAR and pain. Int Rev Neurobiol. 2009;85:165–177. · DOI
  22. 24 Kiguchi N, Maeda T, Kobayashi Y, Saika F, Kishioka S. Chapter 14 involvement of inflammatory mediators in neuropathic pain caused by vincristine. Int Rev Neurobiol. 2009;85:179–190. · DOI
  23. 25 Maeda T, Kiguchi N, Kobayashi Y, Ikuta T, Ozaki M, Kishioka S. Leptin derived from adipocytes in injured peripheral nerves facilitates development of neuropathic pain via macrophage stimulation. Proc Natl Acad Sci U S A. 2009;106: 3076–13081. · DOI
  24. 26 Kiguchi N, Kobayashi Y, Maeda T, Fukazawa Y, Tohya K, Kimura M, et al. Epigenetic augmentation of the MIP-2/CXCR2 axis through histone H3 acetylation in injured peripheral nerves elicits neuropathic pain. J Pharmacol Exp Ther. 2012;340:577–587. · DOI
  25. 27 Iwaszkiewicz KS, Schneider JJ, Hua S. Targeting peripheral opioid receptors to promote analgesic and anti-inflammatory actions. Front Pharmacol. 2013;4:132. · DOI
  26. 28 Schäfer M, Carter L, Stein C. Interleukin 1 b and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc Natl Acad Sci U S A. 1994;91:4219–4223. · DOI
  27. 29 Cabot PJ, Carter L, Gaiddon C, Zhang Q, Schäfer M, Loeffler JP, et al. Immune cell-derived beta-endorphin. Production, release, and control of inflammatory pain in rats. J Clin Invest. 1997;100:142–148. · DOI
  28. 30 Cabot PJ, Carter L, Schäfer M, Stein C. Methionine-enkephalin-and Dynorphin A-release from immune cells and control of inflammatory pain. Pain. 2001;93:207–212. · DOI
  29. 31 Labuz D, Schmidt Y, Schreiter A, Rittner HL, Mousa SA, Machelska H. Immune cell-derived opioids protect against neuropathic pain in mice. J Clin Invest. 2009;119:278–286. · DOI
  30. 32 Kiguchi N, Kobayashi Y, Maeda T, Tominaga S, Nakamura J, Fukazawa Y, et al. Activation of nicotinic acetylcholine receptors on bone marrow-derived cells relieves neuropathic pain accompanied by peripheral neuroinflammation. Neurochem Int. 2012;61:1212–1219. · DOI
  31. 33 Mellon RD, Bayer BM. The effects of morphine, nicotine and epibatidine on lymphocyte activity and hypothalamic-pituitary-adrenal axis responses. J Pharmacol Exp Ther. 1999;288:635–642. · DOI
  32. 34 Lutfy K, Brown MC, Nerio N, Aimiuwu O, Tran B, Anghel A, et al. Repeated stress alters the ability of nicotine to activate the hypothalamic-pituitary-adrenal axis. J Neurochem. 2006;99:1321–1327. · DOI
  33. 36 Abdin MJ, Morioka N, Morita K, Kitayama T, Kitayama S, Nakashima T, et al. Analgesic action of nicotine on tibial nerve transection (TNT)-induced mechanical allodynia through enhancement of the glycinergic inhibitory system in spinal cord. Life Sci. 2006;80:9–16. · DOI
  34. 37 Damaj MI, Meyer EM, Martin BR. The antinociceptive effects of α 7 nicotinic agonists in an acute pain model. Neuropharmacology. 2000;39:2785–2791. · DOI
  35. 38 Marubio LM, del Mar Arroyo-Jimenez M, Cordero-Erausquin M, Léna C, Le Novère N, de Kerchove d’Exaerde A, et al. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature. 1999;398:805–810. · DOI
  36. 39 Smith JS, Schindler AG, Martinelli E, Gustin RM, Bruchas MR, Chavkin C. Stress-induced activation of the dynorphin/κ-opioid receptor system in the amygdala potentiates nicotine conditioned place preference. J Neurosci. 2012;32:1488–1495. · DOI
  37. 40 Childs E1, de Wit H. Effects of acute psychosocial stress on cigarette craving and smoking. Nicotine Tob Res. 2010;12:449–453. · DOI
  38. 41 Walsh K, Elliott JC, Shmulewitz D, Aharonovich E, Strous R, Frisch A, et al. Trauma exposure, posttraumatic stress disorder and risk for alcohol, nicotine, and marijuana dependence in Israel. Compr Psychiatry. 2014. In press. · DOI
  39. 43 Hughes JR, Gust SW, Skoog K, Keenan RM, Fenwick JW. Symptoms of tobacco withdrawal: a replication and extension. Arch Gen Psychiatry. 1991;48:52–59. · DOI · Paper page
  40. 45 Kishioka S, Nishida S, Fukunaga Y, Yamamoto H. Quantitative properties of plasma corticosterone elevation induced by naloxone-precipitated withdrawal in morphine-dependent rats. Jpn J Pharmacol. 1994;66:257–263. · DOI
  41. 46 Ueno K, Maeda T, Kiguchi N, Kobayashi Y, Ozaki M, Kishioka S. Availability of serum corticosterone level for quantitative evaluation of morphine withdrawal in mice. Drug Discov Ther. 2011;5:71–75. · DOI
  42. 47 Martín F, Laorden ML, Milanés MV. Morphine withdrawal regulates phosphorylation of cAMP response element binding protein (CREB) through PKC in the nucleus tractus solitarius-A2 catecholaminergic neurons. J Neurochem. 2009;110:1422–1432. · DOI
  43. 48 Malin DH, Lake JR, Carter VA, Cunningham JS, Wilson OB. Naloxone precipitates nicotine abstinence syndrome in the rat. Psychopharmacology (Berl). 1993;112:339–342. · DOI
  44. 49 Ueno K, Kiguchi N, Kobayashi Y, Saika F, Wakida N, Yamamoto C, et al. Possible involvement of endogenous opioid system located downstream of α 7 nicotinic acetylcholine receptor in mice with physical dependence on nicotine. J Pharmacol Sci. 2014;124:47–53. · DOI
  45. 50 Kumar S, Kumar D, Muniyandi M, Soan V, Pandey M, Mishra DK. Poverty does not limit tobacco consumption among tribal populations: evidence from Central India. Asian Pac J Cancer Prev. 2013;14:6195–6196. · DOI
  46. 54 Williams JM, Steinberg MB, Steinberg ML, Gandhi KK, Ulpe R, Foulds J. Varenicline for tobacco dependence: panacea or plight? Expert Opin Pharmacother. 2011;12:1799–1812. · DOI
  47. 55 Grabus SD, Martin BR, Damaj MI. Nicotine physical dependence in the mouse: Involvement of the α 7 nicotinic receptor subtype. Eur J Pharmacol. 2005;515:90–93. · DOI

Cited by

Sorted by citations

See all 61

Metadata

Authors
Kishioka, S., Kiguchi, N., Kobayashi, Y., & Saika, F.
Venue
Journal of Pharmacological Sciences
Publisher
Japanese Pharmacological Society
Published
2014
Volume
125
Issue
2
Pages
117-124
ISSN
  • 1347-8613
  • 1347-8648
DOI
10.1254/jphs.14r03cp
Cited by
61
References
8
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review